Skip to Content

CBP 200 (Spectracef 200 mg)

Generic Name: cefditoren

Pill imprint CBP 200 has been identified as Spectracef 200 mg.

Spectracef is used in the treatment of skin and structure infection; skin or soft tissue infection; pneumonia; tonsillitis/pharyngitis; bronchitis and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Spectracef 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Spectracef 200 mg CBP 200
Discount Card Promo
Spectracef
Generic Name:
cefditoren
Imprint:
CBP 200
Strength:
200 mg
Color:
White
Size:
17.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Third generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Cornerstone BioPharma Inc
National Drug Code (NDC):
10122-0801
Inactive Ingredients:
carnauba wax
croscarmellose sodium
D&C Red No. 27
mannitol
hydroxypropyl cellulose
hypromelloses
magnesium stearate
polyethylene glycol
propylene glycol
shellac
sodium caseinate
sodium tripolyphosphate
titanium dioxide
FD&C Blue No. 1
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
24486-0801 Aristos Pharmaceuticals Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide